|
1
|
Huang YS, Koo M, Chen JC and Hwang JH: The
association between tinnitus and the risk of ischemic
cerebrovascular disease in young and middle-aged patients: A
secondary case-control analysis of a nationwide, population-based
health claims database. PLoS One. 12:e01874742017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bondonno CP, Blekkenhorst LC, Prince RL,
Ivey KL, Lewis JR, Devine A, Woodman RJ, Lundberg JO, Croft KD,
Thompson PL, et al: Association of vegetable nitrate intake with
carotid atherosclerosis and ischemic cerebrovascular disease in
older women. Stroke. 48:1724–1729. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lai SW, Lin HF, Lin CL and Liao KF:
Long-term effects of pioglitazone on first attack of ischemic
cerebrovascular disease in older people with type 2 diabetes: A
case-control study in Taiwan. Medicine (Baltimore). 95:e44552016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang GQ, Xie YM, Liu H, Zhang Y, Jia PP
and Zhuang Y: Drug combination characteristics of Shenxiong glucose
injection in treating ischemic cerebrovascular disease in real
world. Zhongguo Zhong Yao Za Zhi. 42:2808–2813. 2017.(In Chinese).
PubMed/NCBI
|
|
5
|
Ikeda-Sakai Y, Sasaki M and Nakase T:
Effects with and without clopidogrel loading treatment for acute
ischemic cerebrovascular disease patients: A retrospective cohort
study. J Stroke Cerebrovasc Dis. 26:2901–2908. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zuo FT, Liu H, Wu HJ, Su N, Liu JQ and
Dong AQ: The effectiveness and safety of dual antiplatelet therapy
in ischemic cerebrovascular disease with intracranial and
extracranial arteriostenosis in Chinese patients: A randomized and
controlled trail. Medicine (Baltimore). 96:e54972017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kurz T and Thiele H: Interventional
therapy for aortic valve stenosis. MMW Fortschr Med. 158:49–52.
2016.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Longa EZ, Weinstein PR, Carlson S and
Cummins R: Reversible middle cerebral artery occlusion without
craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qian LH, Li NG, Tang YP, Zhang L, Tang H,
Wang ZJ, Liu L, Song SL, Guo JM and Ding AW: Synthesis and
bio-activity evaluation of scutellarein as a potent agent for the
therapy of ischemic cerebrovascular disease. Int J Mol Sci.
12:8208–8216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sharma VK, Tsivgoulis G, Lao AY and
Alexandrov AV: Role of transcranial Doppler ultrasonography in
evaluation of patients with cerebrovascular disease. Curr Neurol
Neurosci Rep. 7:8–20. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hira RS, Cowart JB, Akeroyd JM, Ramsey DJ,
Pokharel Y, Nambi V, Jneid H, Deswal A, Denktas A, Taylor A, et al:
Risk factor optimization and guideline-directed medical therapy in
US veterans with peripheral arterial and ischemic cerebrovascular
disease compared to veterans with coronary heart disease. Am J
Cardiol. 118:1144–1149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Franzone A, Piccolo R, Gargiulo G, Ariotti
S, Marino M, Santucci A, Baldo A, Magnani G, Moschovitis A,
Windecker S, et al: Prolonged vs short duration of dual
antiplatelet therapy after percutaneous coronary intervention in
patients with or without peripheral arterial disease: A subgroup
analysis of the PRODIGY randomized clinical trial. JAMA Cardiol.
1:795–803. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Della-Morte D, Pacifici F and Rundek T:
Genetic susceptibility to cerebrovascular disease. Curr Opin
Lipidol. 27:187–195. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou Y, Pan Y, Wu Y, Zhao X, Li H, Wang D,
Johnston SC, Liu L, Wang C, Meng X, et al: CHANCE Investigators:
Effect of estimated glomerular filtration rate decline on the
efficacy and safety of clopidogrel with aspirin in minor stroke or
transient ischemic attack: CHANCE substudy (clopidogrel in
high-risk patients with acute nondisabling cerebrovascular events).
Stroke. 47:2791–2796. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Senoo K, Lau YC, Dzeshka M, Lane D,
Okumura K and Lip GY: Efficacy and safety of non-vitamin K
antagonist oral anticoagulants vs. warfarin in Japanese patients
with atrial fibrillation - meta-analysis. Circ J. 79:339–345. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen CH, Lin CL and Kao CH: Subtotal
gastrectomy with billroth II anastomosis is associated with a low
risk of ischemic stroke in peptic ulcer disease patients: A
nationwide population-based study. Medicine (Baltimore).
95:e34812016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Menon BK, Sajobi TT, Zhang Y, Rempel JL,
Shuaib A, Thornton J, Williams D, Roy D, Poppe AY, Jovin TG, et al:
Analysis of workflow and time to treatment on thrombectomy outcome
in the ESCAPE randomized controlled trial. Circulation.
133:2279–2286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ouyang F, Chen Y, Zhao Y, Dang G, Liang J
and Zeng J: Selection of patients and anesthetic types for
endovascular treatment in acute ischemic stroke: A meta-analysis of
randomized controlled trials. PLoS One. 11:e01512102016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang S, Jiang J, Qu C, Wang C and Sun Z:
Predictive value of serum pregnancy-associated plasma protein A for
patients with ischemic cerebrovascular disease. J Clin Lab Anal.
31:22091–22092. 2017. View Article : Google Scholar
|
|
20
|
Singh AG, Crowson CS, Singh S, Denis M,
Davis P, Maradit-Kremers H, Matteson EL and Chowdhary VR: Risk of
cerebrovascular accidents and ischemic heart disease in cutaneous
lupus erythematosus: A population-based cohort study. Arthritis
Care Res (Hoboken). 68:1664–1670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ha M, Choi CH, Lee JI, Cha SH, Lee SW and
Ko JK: The efficacy of single barrel superficial temporal
artery-middle cerebral artery bypass in treatment of adult patients
with ischemic-type moyamoya disease. J Cerebrovasc Endovasc
Neurosurg. 18:239–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rankine-Mullings AE, Little CR, Reid ME,
Soares DP, Taylor-Bryan C, Knight-Madden JM, Stuber SE, Badaloo AV,
Aldred K, Wisdom-Phipps ME, et al: EXpanding treatment for existing
neurological disease (EXTEND): An open-label phase II clinical
trial of hydroxyurea treatment in sickle cell anemia. JMIR Res
Protoc. 5:e1852016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hira RS, Cowart JB, Akeroyd JM, Ramsey DJ,
Pokharel Y, Nambi V, Jneid H, Deswal A, Denktas A, Taylor A, et al:
Risk factor optimization and guideline-directed medical therapy in
US veterans with peripheral arterial and ischemic cerebrovascular
disease compared to veterans with coronary heart disease. Am J
Cardiol. 118:1144–1149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nussbaum ES and Erickson DL:
Extracranial-intracranial bypass for ischemic cerebrovascular
disease refractory to maximal medical therapy. Neurosurgery.
46:37–42. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamazaki M, Ohnishi T, Hosokawa K,
Yamaguchi K, Yoneyama T, Kawashima A, Okada Y, Kitagawa K and
Uchiyama S: Measurement of residual platelet thrombogenicity under
arterial shear conditions in cerebrovascular disease patients
receiving antiplatelet therapy. J Thromb Haemost. 14:1788–1797.
2016. View Article : Google Scholar : PubMed/NCBI
|
